GT199900221A - CCR5 MODULATORS - Google Patents

CCR5 MODULATORS

Info

Publication number
GT199900221A
GT199900221A GT199900221A GT199900221A GT199900221A GT 199900221 A GT199900221 A GT 199900221A GT 199900221 A GT199900221 A GT 199900221A GT 199900221 A GT199900221 A GT 199900221A GT 199900221 A GT199900221 A GT 199900221A
Authority
GT
Guatemala
Prior art keywords
compounds
dosage forms
ccr5
modulators
formulations
Prior art date
Application number
GT199900221A
Other languages
Spanish (es)
Inventor
Duncan Robert Armour
David Anthony Price
Blanda Luzia Christa Stammen
Anthony Wood
Manoussos Perros
Martin Paul Edwards
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT199900221A publication Critical patent/GT199900221A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

ESTA INVENCION SE REFIERE A NUEVOS COMPUESTOS QUIMICOS (LAS ESTRUCTURA SE HALLA SUBDIVIDIDA EN REGIONES POR LO TANTO SE TENDRA QUE BUSCAR EN EL DOCUMENTO ORIGINAL). ESTOS COMPUESTOS ENCUENTRAN UN USO PARTICULAR, AUNQUE NO EXCLUSIVO, COMO COMPUESTOS FARMACEUTICOS, ESPECIALMENTE COMO MODULADORES DE CCR5 DE QUIMIOCINAS (CITOCINAS QUIMIOTACTICAS). ESTA INVENCION TAMBIEN SE REFIERE A FORMULACIONES O FORMAS DE DOSIFICACION QUE INCLUYEN ESTOS COMPUESTOS, AL USO DE ESTOS COMPUESTOS EN LA FABRICACION DE FORMULACIONES FARMACEUTICAS O FORMAS DE DOSIFICACION Y A PROCEDIMIENTOS DE TRATAMIENTO, ESPECIALMENTE EN EL TRATAMIENTO DE ENFERMEDADES Y AFECCIONES ANTIINFLAMATORIAS Y EL TRATAMIENTO Y PREVENCION DE INFECCIONES PRODUCIDAS POR VIH1 Y POR RETROVIRUS RELACIONADOS GENETICAMENTE.THIS INVENTION REFERS TO NEW CHEMICAL COMPOUNDS. THESE COMPOUNDS FIND A PARTICULAR USE, EVEN IF NOT EXCLUSIVE, AS PHARMACEUTICAL COMPOUNDS, ESPECIALLY AS MODULATORS OF CCR5 CHEMIOKINES (CHEMOTOTIC CITOCINES). THIS INVENTION ALSO REFERS TO FORMULATIONS OR DOSAGE FORMS THAT INCLUDE THESE COMPOUNDS, TO THE USE OF THESE COMPOUNDS IN THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS OR DOSAGE FORMS, AND TO PROCESSING OF DISEASES AND AFFECTION. OF INFECTIONS PRODUCED BY HIV1 AND GENETICALLY RELATED RETROVIRUS.

GT199900221A 1998-12-23 1999-12-22 CCR5 MODULATORS GT199900221A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9828420.1A GB9828420D0 (en) 1998-12-23 1998-12-23 CCR5 antagonists useful as anti-hiv agents

Publications (1)

Publication Number Publication Date
GT199900221A true GT199900221A (en) 2001-06-14

Family

ID=10844869

Family Applications (2)

Application Number Title Priority Date Filing Date
GT199900221A GT199900221A (en) 1998-12-23 1999-12-22 CCR5 MODULATORS
GT199900219A GT199900219A (en) 1998-12-23 1999-12-22 CCR5 MODULATORS

Family Applications After (1)

Application Number Title Priority Date Filing Date
GT199900219A GT199900219A (en) 1998-12-23 1999-12-22 CCR5 MODULATORS

Country Status (4)

Country Link
ES (1) ES2362711T3 (en)
GB (1) GB9828420D0 (en)
GT (2) GT199900221A (en)
ZA (2) ZA200104211B (en)

Also Published As

Publication number Publication date
ZA200104211B (en) 2002-01-14
ES2362711T3 (en) 2011-07-12
GT199900219A (en) 2002-03-22
ZA200104254B (en) 2002-11-01
GB9828420D0 (en) 1999-02-17

Similar Documents

Publication Publication Date Title
PA8488101A1 (en) CCR5 MODULATORS
HN2002000154A (en) AZAINDOLS
DE69905170T2 (en) THIAZOLOPYRIMIDINDERIVATE
GT200000014A (en) DERIVATIVES OF QUINOLIN - 2 - ONA SUBSTITUTED WITH HETEROARILO USEFUL AS ANTI-BANERIGAN AGENTS.
ES2045110T3 (en) IMPROVEMENTS IN OR RELATED TO LEUCOTRENE ANTAGONISTS.
DOP2006000269A (en) DERIVATIVES OF 4-AMINO-PIRROLOTRIAZINE REPLACED USEFUL FOR THE TREATMENT OF HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS
SV1999000096A (en) CALCIUM (3S) OF PROPILCARBAMATE TETRAHYDRO 3-FURANIL (1S, 2R) -3 - [[((4-AMINOFENIL) SULFONILO] (ISOBUTILO) AMINO] -1-BENCILO-2- + PHOSPHONOOXILO REF. PG3508 / SV / 0
CY1108578T1 (en) PHARMACEUTICAL COMPOSITIONS (KITS) INCLUDING DIHYDROPYRIDINONES COMPOUNDS AND AN IMMUNE REGULATORY (OR ANTI-FLUID INFECTION)
BR0116052A (en) imidazoquinolines substituted by aryl ether
BRPI0510848A (en) Pyrrolotriazine derivatives useful for the treatment of hyperproliferative disorders and diseases associated with angiogenesis
ES2132855T3 (en) EXTRACT OF IRIDACEAS AND COMPOSITIONS THAT CONTAIN IT.
BG66080B1 (en) Substituted thioacetamides
HRP20080612T3 (en) Combination of tenofovir, ritonavir and tmc114
CY1111567T1 (en) INTERMEDIATE DIVENZO (B, F) AZEPINIS
BR0211729A (en) Compounds, pharmaceutical compositions, process for manufacturing compounds, use of one or more compounds, and process for manufacturing pharmaceutical compositions
GT199900221A (en) CCR5 MODULATORS
DE50310835D1 (en) USE OF A COMPOSITION AND DISINFECTANT CLEANING TABLET CONTAINING THE COMPOSITION
UY26250A1 (en) SULPHONAMIDES REPLACED WITH NAPHTHYL
ATE142075T1 (en) ACTIVE INGREDIENTS FOR COMBATTING VIRUSES OF THE RETROVIRUS GROUP, COMPOSITIONS CONTAINING SAME AND THE USES THEREOF
DE602005023437D1 (en) RITONAVIR ANALOGUE COMPOUND SUITABLE AS AN INHIBITOR OF RETROVIRAL PROTEASE, PREPARATION OF THE RITONAVIR ANALOGIC COMPOUND AND PHARMACEUTICAL COMPOSITION FOR THE RITONAVIR ANALOGIC COMPOUND
ES2026581T3 (en) PLANTS RESISTANT TO INFECTION WITH CUCUMBER MOSAIC VIRUSES.
ECSP044944A (en) SUBSTITUTED DERIVATIVES OF 4-AMINOCICLOHEXANOL
ATE244505T1 (en) HEPATITIS A VIRUCIDE
ES2113333T1 (en) PEPTIDES THAT REACT WITH ANTIBODIES THAT REPRESENT THE FORECAST MARKER OF THE PROGRESSION OF THE AIDS DISEASE.
FR2646607B1 (en) ANTI-B2 MICROGLOBULIN MONOCLONAL ANTIBODIES